Acrivon Therapeutics, Inc.

WELLINGTON MANAGEMENT GROUP LLP ACRV

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

888,130

Value ($000)

2,140

Weight

0.0%

2022 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	2,140	0.0%	888,130	12/31/2025
2025 Q3	11/14/2025	1,608	0.0%	888,130	9/30/2025
2025 Q2	8/14/2025	1,057	0.0%	888,130	6/30/2025
2025 Q1	5/13/2025	1,803	0.0%	888,130	3/31/2025
2024 Q4	2/12/2025	5,347	0.0%	888,130	12/31/2024
2024 Q3	11/14/2024	6,217	0.0%	888,130	9/30/2024
2024 Q2	8/14/2024	5,151	0.0%	888,130	6/30/2024
2024 Q1	5/15/2024	6,350	0.0%	888,130	3/31/2024
2023 Q4	2/12/2024	4,370	0.0%	888,130	12/31/2023
2023 Q3	11/14/2023	8,491	0.0%	888,130	9/30/2023
2023 Q2	8/14/2023	11,510	0.0%	888,130	6/30/2023
2023 Q1	5/12/2023	11,138	0.0%	888,130	3/31/2023
2022 Q4	2/13/2023	9,994	0.0%	900,149	12/31/2022